The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures
- 11 October 2019
- journal article
- research article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 47 (2) , 121-127
Abstract
Background: Bullous pemphigoid (BP) is an autoimmune blistering disease associated with autoantibodies against BP180 and/or BP230 antigens. The immunoassays available for serological diagnostics include indirect immunofluorescence (IIF) on monkey esophagus (ME), salt‐split skin (SSS), and enzyme‐linked immunosorbent assay (ELISA) for BP180‐NC16a and BP230. Only a few studies validated innovative BIOCHIP mosaic, but none compared agreement between BIOCHIP substrates with conventional methods separately.Methods: We evaluated the agreement between BIOCHIP and conventional methods and assessed sensitivity and specificity in BP diagnosis. The study comprised 51 BP patients and 39 controls.Results: Analysis showed very good agreement between BIOCHIP‐SSS vs classic IIF‐SSS (0.933, P < 0.001) and for BIOCHIP‐BP180‐NC16a vs ELISA‐BP180‐NC16a (0.933, P < 0.001). A good strength of agreement between BIOCHIP‐ME vs classic IIF‐ME was observed (0.694, P < 0.001) similar to BIOCHIP‐BP230 vs ELISA‐BP230 (0.793, P < 0.001). BIOCHIP‐ME sensitivity was 51.0%, whereas IIF‐ME was 76.5%. Epidermal reaction on BIOCHIP‐SSS was found in 94.1% of BP patients and in all patients on IIF‐SSS (sensitivity 100%). BIOCHIP‐BP180‐NC16a sensitivity was lower than in ELISA‐BP180‐NC16a (76.5% vs 82.4%). BP230 sensitivity of both methods was similar (45.1% vs 43.1%). The specificity for all antigens was 100%.Conclusion: BIOCHIP mosaic is a useful method presenting satisfactory agreement with conventional immunoassays.Keywords
This publication has 24 references indexed in Scilit:
- Biochip Technology for the Serological Diagnosis of Bullous PemphigoidISRN Dermatology, 2012
- Anti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous DiseasesDermatology, 2012
- Serological diagnosis of autoimmune bullous skin diseases: Prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategyOrphanet Journal of Rare Diseases, 2012
- Autoantibody detection in bullous pemphigoid: Clinical evaluation of the EUROPLUS™ Dermatology MosaicJournal of Immunological Methods, 2012
- Blasenbildende Autoimmundermatosen. Teil 2: Diagnostik und TherapieJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2011
- Clinical Features and Practical Diagnosis of Bullous PemphigoidDermatologic Clinics, 2011
- Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseasesClinics in Dermatology, 2001
- IgG Autoantibodies from Bullous Pemphigoid Patients Recognize Multiple Antigenic Reactive Sites Located Predominantly Within the B and C Subdomains of the COOH-Terminus of BP230Journal of Investigative Dermatology, 2000
- Differentiating Anti-Lamina Lucida and Anti-Sublamina Densa Anti-BMZ Antibodies by Indirect Immunofluorescence on 1.0 M Sodium Chloride-Separated SkinJournal of Investigative Dermatology, 1984
- Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epitheliaCell, 1981